Physician profile
David Todd Whiting
NPI 1023056298
$1,108.23
in general payments reported to CMS, 2019-2025
20 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $49.35 · 2021: $204 · 2022: $129 · 2023: $217 · 2024: $176 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $187.82 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $142.00 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $124.24 | 2020-2025 | Quillichew Er |
| Sobi, INC | $86.83 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $74.04 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $73.70 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $57.42 | 2019-2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $57.29 | 2024-2025 | |
| Quidel Corporation | $51.30 | 2021 | |
| Acadia Pharmaceuticals INC | $42.95 | 2023 | Daybue |
| Seqirus USA INC | $37.34 | 2022-2025 | Flucelvax |
| Pfizer INC. | $32.28 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $24.81 | 2025 | Jornay Pm |
| Biomarin Pharmaceutical INC. | $20.72 | 2022 | |
| Alcon Vision LLC | $18.45 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $18.41 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.55 | 2019 | |
| Shire North American Group INC | $15.02 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.74 | 2019 | |
| Qiagen, LLC | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Whiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.